Minapharm Pharmaceuticals (MIPH) Financials
Annual financial statement highlights for Minapharm Pharmaceuticals covering fiscal years 2006–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025 | — | — | — | — | — | — | — |
| 2024 | 5.66B | 128.22M | 11.5884 | -652.19M | 12B | 5.46B | 2.50 |
| 2023 | 3.89B | -55.39M | -5.0062 | -1.29B | 8.7B | 3.78B | 1.65 |
| 2022 | 3.62B | 589.91M | 51.4136 | -598.44M | 6.81B | 2.43B | 2.80 |
| 2021 | 3.01B | 466.41M | 37.9395 | -182.1M | 4.11B | 1.25B | 2.922 |
| 2020 | 2.36B | 300.78M | 24.4668 | 292.6M | 3.48B | 958.49M | 2.70 |
| 2019 | 2.05B | 141.09M | 11.4769 | -30.22M | 2.89B | 890.36M | 6.00 |
| 2018 | 1.92B | 116.4M | 9.4686 | 2.41M | 2.74B | 802.96M | 6.75 |
| 2017 | 1.65B | 175.39M | 14.2666 | -280.1M | 2.71B | 756.94M | 1.25 |
| 2016 | 1.04B | 32.95M | 2.6806 | 386.84M | 2.02B | 414.13M | 4.50 |
| 2015 | 966.23M | 82.97M | 6.7494 | 118.76M | 1.26B | 275.8M | 4.50 |
| 2014 | 829.6M | 49.34M | 4.0135 | 42.04M | 1.33B | 454.07M | 0.90 |
| 2013 | 712.03M | 81.2M | 6.6054 | 97.71M | 1.11B | 280.2M | 0.90 |
| 2012 | 641.55M | 61.65M | 5.0152 | 6.45M | 891.82M | 176.1M | 1.00 |
| 2011 | 592.45M | 50.97M | 4.1465 | 100.02M | 809.73M | 175.51M | 1.00 |
| 2010 | 533.19M | 77.44M | — | 103.18M | 764.2M | 150.53M | 1.15 |
| 2009 | 381.94M | 65.06M | — | 23.74M | 709.98M | 227.1M | 1.20 |
| 2008 | 336.36M | 60.43M | — | -20.73M | 666.09M | 237.61M | 1.00 |
| 2007 | 275.43M | 41.14M | — | 17.22M | 422.24M | 100.57M | 1.1369 |
| 2006 | 213.75M | 44.13M | — | 12.9M | 354.89M | 66.31M | 1.0818 |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.